DOI: http://dx.doi.org/10.18203/2349-2902.isj20201843

Combined liver-visceral resection for neoplastic lesions correlates with increased postoperative complications

Ashraf Mohammad El-Badry, Mohamed Mahmoud Ali

Abstract


Background: Combined liver-visceral resections (CLVRs) may impose increased risk of postoperative complications. The clinical outcome of CLVRs versus sole liver resection (SLR) has not been adequately reported from upper Egypt cancer surgery programs.

Methods: Medical records of adult non-cirrhotic patients who electively underwent liver resection from February 2015 to April 2018 at Sohag University Hospital, Egypt, were retrospectively reviewed. Indications for liver resection comprised definitively malignant tumors and those with equivocal radiologic features. The severity of surgical complications, including mortality, was compared among patients who underwent CLVRs versus SLR control group with matching age, gender, number of resected liver segments, method of hepatic inflow occlusion and parenchyma transection techniques.

Results: Twenty-six patients were enrolled, including 13 with CLVRs group and their 13 SLR control group. Histopathologic examination of resected specimens confirmed malignancy in 17 patients (10 in CLVR group and 7 in SLR group). Major liver resection (≥3 segments) was carried out in 14 (54%) patients, 7 per each group. The complication score was significantly higher in CLVRs (p<0.05). Similarly, the length of hospital and intensive care unit stays was significantly prolonged in CLVRs group (p<0.05). Overall, 2 patients died (8%), exclusively in the CLVRs. Elderly patients (>65 years) who underwent CLVRs exhibited increased complications compared with their matching controls.

Conclusions: CLVR predisposes to increased morbidity rates and mortality. It should be carried out in carefully selected patients to avoid worse clinical outcome.


Keywords


Colorectal liver metastasis, Liver resection, CLVRs

Full Text:

PDF

References


Pretzsch E. Mechanisms of metastasis in colorectal cancer and metastatic organotropism: hematogenous versus peritoneal spread. J Oncol. 2019;74:7-19.

Cetin B, Bilgetekin I, Cengiz M, Ozet A. Managing synchronous liver metastases in colorectal cancer. Indian J Surg Oncol. 2018;9:461-71.

Adam R, Kitano Y. Multidisciplinary approach of liver metastases from colorectal cancer. Ann Gastroenterol Surg. 2019;3:50-6.

Wakabayashi T. Predictive model for survival after liver resection for noncolorectal liver metastases in the modern era: a Japanese multicenter analysis. J Hepato Biliary Pancreat Sci. 2019;26:441-8.

Hof J, Kok K, Sijmons RH, Jong KP. Systematic review of the prognostic role of the immune system after surgery of colorectal liver metastases. Front Oncol. 2019;9:148.

Reding D. Treatment strategies and outcome of surgery for synchronous colorectal liver metastases. Swiss Med Wkly. 2017;147:14-8.

Tsilimigras DI. Disappearing liver metastases: a systematic review of the current evidence. Surg Oncol. 2019;29:7-13.

Saad AM, Rahman AO. Initial systemic chemotherapeutic and targeted therapy strategies for the treatment of colorectal cancer patients with liver metastases. Expert Opin Pharmacother. 2019;20:1767-75.

Kye BH. Which strategy is better for resectable synchronous liver metastasis from colorectal cancer, simultaneous surgery, or staged surgery? Multicenter retrospective analysis. Ann Surg Treat Res. 2019;97:184-93.

Jones RP, Brudvik KW, Franklin JM, Poston GJ. Precision surgery for colorectal liver metastases: opportunities and challenges of omics-based decision making. Eur J Surg Oncol. 2017;43:875-83.

Gavriilidis P. Simultaneous versus delayed hepatectomy for synchronous colorectal liver metastases: a systematic review and meta-analysis. J Hepat Bilia. 2018;20:11-9.

Chow FCL, Chok KH. Colorectal liver metastases: an update on multidisciplinary approach. World J Hepatol. 2019;11:150-72.

Martin RCG, Augenstein V, Reuter NP, Scoggins CR, McMasters KM. Simultaneous versus staged resection for synchronous colorectal cancer liver metastases. J Am Coll Surg. 2009;208:842-50.

Esposito F. Primary tumor versus liver-first approach for synchronous colorectal liver metastases: an association française de chirurgie (afc) multicenter-based study with propensity score analysis. World J Surg. 2018;42:4046-53.

El-Badry AM, Abdelraheem O. Clinical outcome after liver resection for colorectal versus non-colorectal metastasis: a comparative study. Int Surg J. 2018;5:390-7.

El-Badry AM, Ahmed AE. Evaluation of the “50-50 criteria” of post-hepatectomy liver failure as mortality predictor after resection of liver tumors. Int Surg J. 2019;6:648-52.

Abdelhameed HF, El-Badry AM. Cirrhosis aggravates the ninety-day mortality after liver resection for hepatocellular carcinoma. Int Surg J. 2019;6:2869-75.

El-Badry AM, Abusedera MA, Ali HM. Postoperative thrombocytopenia aggravates liver dysfunction after resection of hepatocellular carcinoma in the cirrhotic liver. HPB. 2019;21:982.

El-Badry AM, Graf R, Clavien PA. Omega 3 - Omega 6: what is right for the liver? J Hepatol. 2007;7:718-25.

Clavien PA. What is critical for liver surgery and partial liver transplantation: size or quality? Hepatol Baltim Md. 2010;52:715-29.

El-Badry AM. Prevention of reperfusion injury and microcirculatory failure in macrosteatotic mouse liver by omega-3 fatty acids. Hepatol Baltim Md. 2007;45:855-63.

El-Badry AM. Chemical composition of hepatic lipids mediates reperfusion injury of the macrosteatotic mouse liver through thromboxane. J Hepatol. 2011;55:1291-9.

Nakajima K. Predictive factors for anastomotic leakage after simultaneous resection of synchronous colorectal liver metastasis. J Gastrointest Surg. 2012;16:821-7.

Moggia E. Methods to decrease blood loss during liver resection: a network meta-analysis. Cochrane Database Syst Rev. 2016;10:CD010683.

Mahfud M. Impact of preoperative bevacizumab on complications after resection of colorectal liver metastases: case-matched control study. World J Surg. 2010;34:92-100.

Kawamura J. Clinical efficacy of liver resection after downsizing systemic chemotherapy for initially unresectable liver metastases. World J Surg Oncol. 2016;14:56.

Mentha G. ‘Liver first’ approach in the treatment of colorectal cancer with synchronous liver metastases. Dig Surg. 2008;25:430-5.

Passot G, Vauthey JN. In favor of two-stage hepatectomy (TSH). Eur J Surg Oncol. 2015;41:1566-7.

Shubert CR. A NSQIP review of major morbidity and mortality of synchronous liver resection for colorectal metastasis stratified by extent of liver resection and type of colorectal resection. J Gastrointest Surg Off. 2015;19:1982-94.

Clarke NAR, Kanhere HA, Trochsler MI, Maddern GJ. Liver resection for non-colorectal non-neuroendocrine metastases. Anz J Surg. 2016;5:137-40.

Martel G. Liver resection for non-colorectal, non-carcinoid, non-sarcoma metastases: a multicenter study. PloS One. 2015;10:e0120569.